MENU
ZTS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

ZOETIS (ZTS) Ownership - Who owns ZOETIS?

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals... Show more

Profile

Industry
Pharmaceuticals Generic
Address
10 Sylvan Way
Phone
+1 973 822-7000
Employees
14100
Web
https://www.zoetis.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
53.43B
P/E Ratio
20.41
Total Cash
N/A
Projected Growth
2.28
Total Debt
6.79B
Revenue
9.4B
Risk (Beta)
N/A
Dividend Yield
0.02
Total Cash/Share
N/A
Total Debt/Equity
332.85
Revenue/Share
21.02 USD as % of share price

Fundamentals

ZTS
Capitalization
53.4B
P/E Ratio
20.41
Risk (Beta)
N/A
Dividend Yield
0.02
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
6.79B
Total Debt/Equity
332.85
Projected Growth (PEG Ratio)
2.28
Revenue/Share (as % of the share price)
21.02%
Revenue
9.4B
ROE
N/A
Book Value
4.98B
P/B Ratio
9.90
Cash Flow
N/A
Earnings
5.94
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5M
Current Ratio
1.76
Current Revenue Per Employee
178260.88
Dividends Per Share - Security
0.50
EBITDA
4.04B
Float
N/A
Float - Current
N/A
Gross Income Margin
73.62
Revenue To Assets
17.96
Shares Held By Institutions
N/A
Shares Outstanding - Current
441M
Total Liabilities
9.5B
Total Volume MTD
N/A
Value
1
Gain YTD
-24.593
View a ticker or compare two or three
ZTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ZTS showed earnings on November 04, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a pet medication company

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
10 Sylvan Way
Phone
+1 973 822-7000
Employees
14100
Web
https://www.zoetis.com